Bonaventure Ip
@IpBonaventure
Stroke neurologist and neurointerventionist @ Prince of Wales Hospital, CUHK
ID:1372735825058746371
19-03-2021 02:25:06
164 Tweets
74 Followers
109 Following
A cross-disciplinary research team from CUHK Engineering & CUHK Medicine develops retrievable nanorobots for targeted and enhanced thrombolysis, potentially saving stroke patients from brain damage. Published in #ScienceAdvances #ScienceRobotics . Details: bit.ly/3VIovFE
New non-randomized comparidon of andexanet alfa and usual care (i.e. PCC and/or TXA) in patients with factorXa-inhibitor- ICH - high rate of continuous bleeding (aka haematoma expansion) with usual care. Andexanet was associated with lower incidence of HE Stroke Research Center Bern Bernhard Siepen
Bonaventure Ip et al. provide overview of the pathophysiology of vascular cognitive impairment, and outline how an understanding of underlying mechanisms may inform the development of novel therapies. Ho Ko Bonnie Lam Vincent Mok CUHK Neurology
ahajournals.org/doi/10.1161/ST…
Now we need to improve secondary prevention strategies for vulnerable patient groups like those with a history of ICH #ENRICH -AF PHRI.ca Population Health Research Institute 🇨🇦 and those with #breakthroughstrokes despite anticoagulation with our Schweizerischer Nationalfonds (SNF) funded ELAPSE Urs Martin Fischer Lorenz Räber, MD PhD
In a Review, David Seiffge and colleagues provide an update on secondary stroke prevention in people with atrial fibrillation: thelancet.com/journals/laneu…
@strokebern
@ash_shoamanesh
@fishingNeurons
Valeria Castro
@UCLstrokeRes
@raberLorenz
Statin use in stroke patients with CMBs?
Likely rather beneficial than harmful, even in those with multiple CMBs! #microbleeds Neurology Journal
neurology.org/doi/10.1212/WN…
Interested in learning more regarding predictors of hematoma expansion and response to andexanet alfa in patients with FXaI-associated ICH participating in the ANNEXa-I trial?
I summarize our findings with NeurologyLive here:
neurologylive.com/view/secondary…
#neurotwitter McMaster University Department of Medicine
Happy to share our study showing that APOE e4 is a risk factor for ICH in pts with brain AVMs.
- Odds ratio of 4 > promising role in prediction
- CAA is the mediating mechanism?
Thank you Daniela Renedo for your leadership.
Please take a look! shorturl.at/azS08
Via #ISC24 : #COVID19 vaccination does not worsen imaging markers of #CerebrovascularDisease : bit.ly/4bCmvUF
#NeuroTwitter #coronavirus @AANMember AHA Science CUHK Neurology Upstate Medical University
This retrospective study suggests that changing pre-stroke DOAC does not reduce recurrent cerebral ischemia in patients with #AtrialFibrillation who develop ischemic stroke on DOAC therapy. #AHAJournals ahajrnls.org/3UIDBKM
Spectrum of OAC-ICH changed dramatically, FXaI now the majority. Poor outcomes with current reversal, need better treatments. Great Norwegian-Swiss collaboration Stroke Research Center Bern Bernhard Siepen Espen Saxhaug Kristoffersen Johannes Kaesmacher Thomas Meinel Urs Martin Fischer Martina Göldlin
svn.bmj.com/content/early/…